urethane has been researched along with Adenocarcinoma in 68 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this paper, we extended our work and examined the effects of I3C (70 or 30 micromol/g diet) and MI (56 micromol/g diet) against vinyl carbamate (VC)-induced lung adenocarcinoma by administering the agents from 1 week after the second of two injections of VC until termination of the study at week 18." | 7.76 | Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice. ( Hecht, SS; Kalscheuer, S; Kassie, F; Ma, L; Matise, I; Melkamu, T; Upadhyaya, P, 2010) |
| "Urethane-induced lung carcinogenesis led to more M2 macrophage phenotype and increased abnormal angiogenesis concomitant with the upregulation of LC3-B and the downregulation of p62." | 5.43 | The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis. ( Cao, N; Du, GJ; Geng, SN; Guo, ZZ; Han, G; Li, GG; Lin, HH; Ma, XF; Meng, MJ; Zheng, YQ, 2016) |
| " The effects of activating GPER and function of G15 were analyzed in the proliferation of A549 and H1793 cell lines and development of urethane-induced adenocarcinoma." | 3.91 | G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer. ( Fan, S; Fu, X; Liao, Y; Liu, C; Wang, J; Xiong, J; Zhou, S; Zou, M, 2019) |
| " XPC-/- mice treated with the CS-carcinogen urethane developed lung adenocarcinomas representing progressive stages of tumor development, with lung tumor number increased 17-fold compared with XPC+/+ mice." | 3.91 | XPC protects against smoking- and carcinogen-induced lung adenocarcinoma. ( Saliba, J; Sandusky, GE; Sears, CR; Zhou, H, 2019) |
| " Additionally, in vitro administration of E2 and G1 increased the number of tumor nodules, tumor grade, and tumor index in a urethane-induced adenocarcinoma model." | 3.81 | G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1. ( Fan, S; Jiang, Z; Liao, Y; Liu, C; Tang, H; Wang, J; Xiong, J; Zhou, B; Zhou, S; Zou, M, 2015) |
| " A mouse model of urethane-induced lung adenocarcinoma was used in the study." | 3.80 | Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression. ( Chen, G; Fu, S; Liao, Y; Liu, Z; Tang, H; Xu, L; Yu, L; Zhang, C; Zhou, S, 2014) |
| " In this paper, we extended our work and examined the effects of I3C (70 or 30 micromol/g diet) and MI (56 micromol/g diet) against vinyl carbamate (VC)-induced lung adenocarcinoma by administering the agents from 1 week after the second of two injections of VC until termination of the study at week 18." | 3.76 | Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice. ( Hecht, SS; Kalscheuer, S; Kassie, F; Ma, L; Matise, I; Melkamu, T; Upadhyaya, P, 2010) |
| " Lung adenocarcinomas were induced in A/J mice by injection of the carcinogen vinyl carbamate." | 3.75 | Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice. ( Liby, K; Ma, T; Risingsong, R; Royce, DB; Sporn, MB; Williams, CR; Yore, MM, 2009) |
| " Female A/J mice were treated with the mutagenic carcinogen vinyl carbamate, which induces adenocarcinoma of the lung in all animals within 16 weeks." | 3.74 | The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. ( Dmitrovsky, E; Gribble, GW; Honda, T; Liby, K; Risingsong, R; Royce, DB; Sporn, MB; Sporn, TA; Williams, CR; Yore, MM, 2007) |
| " The goal of this work was to monitor quantitatively the development and progression of adenocarcinoma in a time course study of mice treated with the carcinogen urethane using in vivo small-animal magnetic resonance imaging (MRI)." | 3.74 | Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging. ( Garbow, JR; Lubet, RA; Wang, M; Wang, Y; You, M, 2008) |
| "In the A/J strain of mice, urethane (ethyl carbamate) induces lung hyperplasia, adenoma, and adenocarcinoma in a time-dependent manner." | 3.69 | Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. ( Chen, A; Horio, Y; Malkinson, AM; Rice, P; Roth, JA; Schrump, DS, 1996) |
| "Urethane-induced lung carcinogenesis led to more M2 macrophage phenotype and increased abnormal angiogenesis concomitant with the upregulation of LC3-B and the downregulation of p62." | 1.43 | The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis. ( Cao, N; Du, GJ; Geng, SN; Guo, ZZ; Han, G; Li, GG; Lin, HH; Ma, XF; Meng, MJ; Zheng, YQ, 2016) |
| "Lung cancer is the leading cause of cancer-related death worldwide." | 1.38 | Non-invasive X-ray micro-computed tomographic evaluation of indomethacin on urethane-induced lung carcinogenesis in mice. ( Hayakawa, T; Imai, T; Imaida, K; Komiya, M; Mutoh, M; Takahashi, M; Tsuta, K; Ueno, T; Wakabayashi, K; Yanaka, A; Yoshimoto, M, 2012) |
| "Lung cancer is one of the most important avoidable causes of death around the world, the most widespread carcinoma, with a very poor prognosis, and is the leading cause of cancer death in both developed and developing countries." | 1.37 | Characterization of a murine lung adenocarcinoma (LAC1), a useful experimental model to study progression of lung cancer. ( Díaz, Mdel P; Eynard, AR; Ortiz, S; Piegari, M; Valentich, MA, 2011) |
| "When pioglitazone was administered beginning 8 weeks after the first carcinogen treatment when microscopic adenomas already existed, pioglitazone significantly inhibited tumor load (sum of tumor volume per lung in average) by 64% (P < 0." | 1.36 | Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice. ( James, M; Lu, Y; Lubet, RA; Szabo, E; Wang, Y; Wen, W; You, M, 2010) |
| "Urethane treatment accelerated number and size of lung tumors developing in SOPten(flox/flox) mice of both ages." | 1.34 | Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. ( Hamada, K; Horie, Y; Kawahara, K; Kishimoto, H; Kubo, H; Mak, TW; Nakano, T; Nakazato, M; Nishio, M; Sasaki, M; Sasaki, T; Suzuki, A; Whitsett, JA; Yajima, N; Yanagi, S, 2007) |
| "Bexarotene (Targretin), is a synthetic high-affinity RXR receptor agonist with limited affinity for RAR receptors." | 1.33 | Prevention of lung cancer progression by bexarotene in mouse models. ( Jia, D; Lubet, RA; Wang, D; Wang, Y; Yao, R; You, M; Zhang, Z, 2006) |
| " Ten weekly ethyl carbamate (EC) doses caused a nearly 100% lung tumor incidence with a tumor multiplicity >2; multiple EC dosing is thus an alternative to the time-consuming transfer of transgenes and null mutations to susceptible backgrounds." | 1.32 | Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections. ( Dwyer-Nield, LD; Franklin, WA; Keith, RL; Le, M; Malkinson, AM; Miller, YE, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (38.24) | 18.7374 |
| 1990's | 6 (8.82) | 18.2507 |
| 2000's | 19 (27.94) | 29.6817 |
| 2010's | 17 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C | 2 |
| Liao, Y | 3 |
| Fan, S | 2 |
| Fu, X | 1 |
| Xiong, J | 2 |
| Zhou, S | 3 |
| Zou, M | 2 |
| Wang, J | 2 |
| Zhou, H | 1 |
| Saliba, J | 1 |
| Sandusky, GE | 1 |
| Sears, CR | 1 |
| Satoh, H | 1 |
| Moriguchi, T | 1 |
| Takai, J | 1 |
| Ebina, M | 2 |
| Yamamoto, M | 1 |
| Jan Treda, C | 1 |
| Fukuhara, T | 1 |
| Suzuki, T | 1 |
| Nakamura, A | 1 |
| Zaini, J | 1 |
| Kikuchi, T | 1 |
| Nukiwa, T | 1 |
| Westcott, PM | 1 |
| Halliwill, KD | 1 |
| To, MD | 1 |
| Rashid, M | 1 |
| Rust, AG | 1 |
| Keane, TM | 1 |
| Delrosario, R | 1 |
| Jen, KY | 1 |
| Gurley, KE | 1 |
| Kemp, CJ | 1 |
| Fredlund, E | 1 |
| Quigley, DA | 1 |
| Adams, DJ | 1 |
| Balmain, A | 1 |
| Yun, HM | 1 |
| Park, KR | 1 |
| Park, MH | 1 |
| Kim, DH | 1 |
| Jo, MR | 1 |
| Kim, JY | 1 |
| Kim, EC | 1 |
| Yoon, DY | 1 |
| Han, SB | 1 |
| Hong, JT | 1 |
| Tang, H | 2 |
| Zhang, C | 1 |
| Chen, G | 1 |
| Xu, L | 1 |
| Liu, Z | 1 |
| Fu, S | 1 |
| Yu, L | 1 |
| Jiang, Z | 1 |
| Zhou, B | 1 |
| Tsuji, S | 1 |
| Kuwahara, Y | 1 |
| Takagi, H | 1 |
| Sugiura, M | 1 |
| Nakanishi, Y | 1 |
| Wakamatsu, M | 1 |
| Tsuritani, K | 1 |
| Sato, Y | 1 |
| Li, GG | 1 |
| Guo, ZZ | 1 |
| Ma, XF | 1 |
| Cao, N | 1 |
| Geng, SN | 1 |
| Zheng, YQ | 1 |
| Meng, MJ | 1 |
| Lin, HH | 1 |
| Han, G | 1 |
| Du, GJ | 1 |
| Kassie, F | 2 |
| Kalscheuer, S | 1 |
| Matise, I | 1 |
| Ma, L | 1 |
| Melkamu, T | 2 |
| Upadhyaya, P | 1 |
| Hecht, SS | 1 |
| Herzog, CR | 3 |
| Blake, DC | 1 |
| Mikse, OR | 1 |
| Grigoryeva, LS | 1 |
| Gundermann, EL | 1 |
| Zhang, X | 1 |
| Tan, J | 1 |
| Zeng, Y | 1 |
| Liby, K | 2 |
| Risingsong, R | 2 |
| Royce, DB | 2 |
| Williams, CR | 2 |
| Ma, T | 1 |
| Yore, MM | 2 |
| Sporn, MB | 2 |
| Lee, KS | 1 |
| Lee, YS | 1 |
| Lee, JM | 1 |
| Ito, K | 1 |
| Cinghu, S | 1 |
| Kim, JH | 1 |
| Jang, JW | 1 |
| Li, YH | 1 |
| Goh, YM | 1 |
| Chi, XZ | 1 |
| Wee, H | 1 |
| Lee, HW | 1 |
| Hosoya, A | 1 |
| Chung, JH | 1 |
| Jang, JJ | 1 |
| Kundu, JK | 1 |
| Surh, YJ | 1 |
| Kim, WJ | 1 |
| Ito, Y | 1 |
| Jung, HS | 1 |
| Bae, SC | 1 |
| Karoor, V | 1 |
| Le, M | 2 |
| Merrick, D | 1 |
| Dempsey, EC | 1 |
| Miller, YE | 2 |
| Wang, Y | 4 |
| James, M | 1 |
| Wen, W | 1 |
| Lu, Y | 1 |
| Szabo, E | 2 |
| Lubet, RA | 6 |
| You, M | 6 |
| Piegari, M | 2 |
| Ortiz, S | 1 |
| Díaz, Mdel P | 1 |
| Eynard, AR | 2 |
| Valentich, MA | 2 |
| Ueno, T | 1 |
| Imaida, K | 1 |
| Yoshimoto, M | 1 |
| Hayakawa, T | 1 |
| Takahashi, M | 1 |
| Imai, T | 1 |
| Yanaka, A | 1 |
| Tsuta, K | 1 |
| Komiya, M | 1 |
| Wakabayashi, K | 1 |
| Mutoh, M | 1 |
| Pereira, MA | 2 |
| Li, Y | 1 |
| Gunning, WT | 2 |
| Kramer, PM | 2 |
| Al-Yaqoub, F | 1 |
| Steele, VE | 2 |
| Tao, L | 1 |
| Kang, Y | 1 |
| Ozbun, LL | 1 |
| Angdisen, J | 1 |
| Moody, TW | 1 |
| Prentice, M | 1 |
| Diwan, BA | 1 |
| Jakowlew, SB | 2 |
| Devereux, TR | 2 |
| Pittman, B | 2 |
| Dwyer-Nield, LD | 2 |
| Keith, RL | 1 |
| Franklin, WA | 1 |
| Malkinson, AM | 5 |
| ELION, GB | 1 |
| BIEBER, S | 1 |
| HITCHINGS, GH | 1 |
| SCHOENTAL, R | 2 |
| Zhang, F | 1 |
| Pao, W | 1 |
| Umphress, SM | 1 |
| Meyer, AM | 1 |
| Nielsen, LD | 1 |
| Takeda, K | 1 |
| Gelfand, EW | 1 |
| Fisher, JH | 1 |
| Zhang, L | 1 |
| Mason, RJ | 1 |
| Bodon, N | 1 |
| Maronpot, RR | 1 |
| Massey, TE | 1 |
| Anderson, MW | 1 |
| Ozaki, M | 1 |
| Ozaki, K | 1 |
| Watanabe, T | 1 |
| Uwagawa, S | 1 |
| Okuno, Y | 1 |
| Shirai, T | 2 |
| Zhang, Z | 2 |
| Yao, R | 1 |
| Jia, D | 1 |
| Wang, D | 1 |
| Kim, IM | 1 |
| Ackerson, T | 1 |
| Ramakrishna, S | 1 |
| Tretiakova, M | 1 |
| Wang, IC | 1 |
| Kalin, TV | 1 |
| Major, ML | 1 |
| Gusarova, GA | 1 |
| Yoder, HM | 1 |
| Costa, RH | 1 |
| Kalinichenko, VV | 1 |
| Redente, EF | 1 |
| Orlicky, DJ | 1 |
| Bouchard, RJ | 1 |
| Honda, T | 1 |
| Gribble, GW | 1 |
| Dmitrovsky, E | 1 |
| Sporn, TA | 1 |
| Yanagi, S | 1 |
| Kishimoto, H | 1 |
| Kawahara, K | 1 |
| Sasaki, T | 1 |
| Sasaki, M | 1 |
| Nishio, M | 1 |
| Yajima, N | 1 |
| Hamada, K | 1 |
| Horie, Y | 1 |
| Kubo, H | 1 |
| Whitsett, JA | 1 |
| Mak, TW | 1 |
| Nakano, T | 1 |
| Nakazato, M | 1 |
| Suzuki, A | 1 |
| Garbow, JR | 1 |
| Wang, M | 1 |
| Masuda, A | 1 |
| Hirose, M | 1 |
| Ikawa, E | 1 |
| Ito, N | 1 |
| Imai, S | 1 |
| Morimoto, J | 1 |
| Tsubura, Y | 1 |
| Hilgers, J | 1 |
| Hirono, I | 1 |
| Hosaka, S | 1 |
| Kuhara, K | 1 |
| Kawano, R | 1 |
| Nishisaka, T | 1 |
| Takeshima, Y | 1 |
| Yonehara, S | 1 |
| Inai, K | 1 |
| Horio, Y | 1 |
| Chen, A | 1 |
| Rice, P | 1 |
| Roth, JA | 1 |
| Schrump, DS | 1 |
| Mohr, U | 1 |
| Dasenbrock, C | 1 |
| Tillmann, T | 1 |
| Kohler, M | 1 |
| Kamino, K | 1 |
| Hagemann, G | 1 |
| Morawietz, G | 1 |
| Campo, E | 1 |
| Cazorla, M | 1 |
| Fernandez, P | 1 |
| Hernandez, L | 1 |
| Cardesa, A | 1 |
| Tomatis, L | 1 |
| Hiai, H | 1 |
| Abujiang, P | 1 |
| Nishimura, M | 1 |
| Salvador, AF | 1 |
| Muñoz, SE | 1 |
| Kawai, T | 1 |
| Matsuzawa, A | 1 |
| Yamamoto, T | 1 |
| Mizuno, Y | 1 |
| Sonntag, AC | 1 |
| Medina, D | 2 |
| Warner, MR | 1 |
| Goldfeder, A | 1 |
| Bhide, SV | 1 |
| Sirsat, MV | 1 |
| Anisimov, VN | 1 |
| Pan, YH | 1 |
| Nuzum, EO | 2 |
| Hanson, LA | 1 |
| Beer, DG | 2 |
| Parsons, DF | 1 |
| Foley, J | 1 |
| Marko, M | 1 |
| Wansor, K | 1 |
| Yamamoto, H | 1 |
| Fujishiro, K | 1 |
| Yamamoto, I | 1 |
| Vesselinovitch, SD | 1 |
| Mihailovich, N | 1 |
| Pietra, G | 1 |
| Nomura, T | 1 |
| Okada, Y | 1 |
| Krakoff, IH | 1 |
| Clifford, GO | 1 |
| Cioli, V | 1 |
| Scorza Barcellona, P | 1 |
| Silvestrini, B | 1 |
| Shabad, LM | 1 |
| Toth, B | 2 |
| Bensted, JP | 1 |
| Smithers, D | 1 |
| Bennett, LL | 1 |
| Struck, RF | 1 |
4 reviews available for urethane and Adenocarcinoma
| Article | Year |
|---|---|
Polygenic resistance to mouse pulmonary adenomas.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chromosomes, Huma | 2000 |
Xenobiotics and molecular teratology.
Topics: Abnormalities, Drug-Induced; Adenocarcinoma; Animals; Carcinogens; Diethylstilbestrol; Drug Interact | 1975 |
More about isonicotinic acid hydrazide toxicity.
Topics: Adenocarcinoma; Adenofibroma; Adenoma; Animals; Carcinoma; Chemical and Drug Induced Liver Injury; C | 1970 |
Further chapters in the hydrazine story.
Topics: Adenocarcinoma; Anemia, Hemolytic; Animals; Carbon Isotopes; Carcinogens; Colonic Neoplasms; Criceti | 1971 |
1 trial available for urethane and Adenocarcinoma
| Article | Year |
|---|---|
Clinical studies of n-hydroxyurethan (NSC-83629).
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Male; Melano | 1968 |
63 other studies available for urethane and Adenocarcinoma
| Article | Year |
|---|---|
G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
Topics: A549 Cells; Adenocarcinoma; Animals; Benzodioxoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor | 2019 |
XPC protects against smoking- and carcinogen-induced lung adenocarcinoma.
Topics: Adenocarcinoma; Animals; Carcinogens; Cigarette Smoking; DNA Damage; Female; Humans; Lung Neoplasms; | 2019 |
Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.
Topics: Adenocarcinoma; Animals; Base Sequence; Cell Transformation, Neoplastic; Cytochrome P-450 CYP2E1; DN | 2013 |
Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.
Topics: Adenocarcinoma; Animals; Base Sequence; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; DNA Pr | 2014 |
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplasti | 2015 |
PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model.
Topics: Adenocarcinoma; Animals; Chemokine CCL5; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Glut | 2015 |
Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents, Hormonal; Carcinogenesis; Disease Model | 2014 |
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Non-Small-Cell | 2015 |
Gene expression analysis in the lung of the rasH2 transgenic mouse at week 4 prior to induction of malignant tumor formation by urethane and N-methylolacrylamide.
Topics: Acrylamides; Adenocarcinoma; Adenoma; Animals; Aurora Kinase B; Biomarkers, Tumor; Carcinoembryonic | 2015 |
The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Autophagy; Benzofurans; Capillary Permea | 2016 |
Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Prol | 2010 |
FoxO3a gene is a target of deletion in mouse lung adenocarcinoma.
Topics: Adenocarcinoma; Aflatoxin B1; Animals; Carcinogens; Disease Models, Animal; Forkhead Box Protein O3; | 2009 |
Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Blotting, Western; Female; Gene Expression Profili | 2010 |
Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice.
Topics: Adenocarcinoma; Animals; Cell Proliferation; Fatty Acids, Unsaturated; Female; Ligands; Lung Neoplas | 2009 |
Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.
Topics: Adenocarcinoma; Animals; Cell Differentiation; Cell Proliferation; Core Binding Factor Alpha 3 Subun | 2010 |
Vascular endothelial growth factor receptor 2-targeted chemoprevention of murine lung tumors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carc | 2010 |
Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Chemopreventi | 2010 |
Characterization of a murine lung adenocarcinoma (LAC1), a useful experimental model to study progression of lung cancer.
Topics: Adenocarcinoma; Animals; Cell Proliferation; Cells, Cultured; Concanavalin A; Erythrocyte Count; Hem | 2011 |
Non-invasive X-ray micro-computed tomographic evaluation of indomethacin on urethane-induced lung carcinogenesis in mice.
Topics: Adenocarcinoma; Adenoma; Animals; Antineoplastic Agents; Carcinogens; Humans; Hyperplasia; Immunohis | 2012 |
Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Budesonide; Cell Divis | 2002 |
Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.
Topics: Adenocarcinoma; Animals; Cell Cycle Proteins; Cell Division; DNA Primers; Female; G1 Phase; Gene Exp | 2002 |
Carcinogenic induction directs the selection of allelic losses in mouse lung tumorigenesis.
Topics: Adenocarcinoma; Animals; Carcinogens; Loss of Heterozygosity; Lung Neoplasms; Mice; Mice, Inbred A; | 2002 |
Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections.
Topics: Adenocarcinoma; Animals; Butylated Hydroxytoluene; Carcinogens; Disease Models, Animal; Incidence; L | 2003 |
Studies on the mechanism of action of urethane on mammary adenocarcinoma 755.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Humans; Mammary Neoplasms, Experimental; Urethane | 1960 |
INDUCTION OF TUMOURS OF THE STOMACH IN RATS AND MICE BY N-NITROSO-NALKYLURETHANES.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma; Carcinoma, Squamous Cell; Mice; Neoplasms, Experime | 1963 |
Serum levels of surfactant protein D are increased in mice with lung tumors.
Topics: Adenocarcinoma; Animals; Carcinogens; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, | 2003 |
Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression.
Topics: Adenocarcinoma; Animals; Carcinogens; Chromosomal Instability; Chromosome Deletion; Chromosome Mappi | 2004 |
Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains.
Topics: Adenocarcinoma; Adenoma; Animals; Body Weight; Disease Models, Animal; Genes, p53; Genes, ras; Genet | 2005 |
A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Topics: Adenocarcinoma; Animals; Cocarcinogenesis; Disease Models, Animal; Disease Progression; Genes, ras; | 2006 |
Prevention of lung cancer progression by bexarotene in mouse models.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Bexarotene; Carcinogens; Carcinoma, Non-S | 2006 |
The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.
Topics: Adenocarcinoma; Alleles; Animals; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Growth Process | 2006 |
Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice.
Topics: Adenocarcinoma; Adenoma; Animals; Biomarkers, Tumor; Bone Marrow; Carcinogens; Cell Transformation, | 2007 |
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Humans; Lung; Lung Ne | 2007 |
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.
Topics: Adenocarcinoma; Animals; Bronchi; Cell Transformation, Neoplastic; Gene Expression; Lung; Lung Neopl | 2007 |
Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging.
Topics: Adenocarcinoma; Animals; Carcinogens; Disease Models, Animal; Image Interpretation, Computer-Assiste | 2008 |
Enhancement of N-bis(2-hydroxypropyl)nitrosamine-initiated lung tumor development in rats by bleomycin and N-methyl-N-nitrosourethane.
Topics: Adenocarcinoma; Animals; Bleomycin; Carcinogens; Drug Synergism; Hyperplasia; Lung; Lung Neoplasms; | 1984 |
Mammary tumor induction in inbred mouse strains with urethane is not accompanied by changes in expression of B- and C-type retroviral structural proteins.
Topics: Adenocarcinoma; Animals; Antigens, Viral; Disease Susceptibility; Female; Gammaretrovirus; Leukemia | 1982 |
Enhancement by bracken of induction of tumours of the upper alimentary tract by N-propyl-N-nitrosourethan.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Gastrointestinal Ne | 1982 |
Role of point mutation of the K-ras gene in tumorigenesis of B6C3F1 mouse lung lesions induced by urethane.
Topics: Adenocarcinoma; Adenoma; Animals; Base Sequence; Disease Models, Animal; Dose-Response Relationship, | 1995 |
Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Topics: Adenocarcinoma; Adenoma; Animals; Base Sequence; Carcinogens; Disease Progression; Exons; Genes, p53 | 1996 |
Possible carcinogenic effects of X-rays in a transgenerational study with CBA mice.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Cocarcinogenesis; Female; Genes, ras; Hematologic Neo | 1999 |
Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Carcinogens; Chemoprevention; Dexamethaso | 2000 |
Delayed-type hypersensitivity and humoral immunity modulation by dietary lipids in a murine model of pulmonary tumorigenesis induced by urethan.
Topics: Adenocarcinoma; Animals; Antibody Formation; Carcinogens; Dietary Fats, Unsaturated; Disease Models, | 2001 |
Histopathological studies on experimentally induced pulmonary, pleural and peritoneal neoplasms in mice by intraperitoneal injection of chrysotile asbestos and N-methyl-N-nitrosourethane.
Topics: Adenocarcinoma; Animals; Asbestos; Female; Injections, Intraperitoneal; Lung Neoplasms; Male; Mice; | 1979 |
An ovary-dependent mouse mammary tumor induced by urethan.
Topics: Adenocarcinoma; Animals; Estrogens; Female; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, | 1977 |
Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Age Factors; Animals; Female; Hyperplasia; Mammary | 1976 |
Induction of type B virions to bud into cytoplasmic vacuoles in a mammary tumor of an X-ray- and urethan-treated X/Gf mouse.
Topics: Adenocarcinoma; Animals; Cell Membrane; Cytoplasm; Mammary Neoplasms, Experimental; Mice; Mice, Inbr | 1976 |
Biological studies on the effect of DNA extracted from urethan treated mice.
Topics: Adenocarcinoma; Animals; Animals, Newborn; DNA; Embryo, Mammalian; Fatty Liver; Female; Lung Neoplas | 1975 |
Two-step carcinogenesis induced by neonatal exposure to 5-bromo-2'- deoxyuridine and subsequent administration of urethan in BALB/c mice.
Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Body Weight; Bromodeoxyuridine; Cocarcinogenesis | 1992 |
Ki-ras activation and expression in transformed mouse lung cell lines.
Topics: Adenocarcinoma; Adenoma; Animals; Base Sequence; Cell Division; Cell Transformation, Neoplastic; Gen | 1990 |
Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas.
Topics: Adenocarcinoma; Adenoma; Animals; Codon; Gene Expression; Lung Neoplasms; Mice; Mice, Inbred A; Muta | 1990 |
Immediate ascites conversion of mammary tumors induced in NYLR/Nya mice by 7,12-dimethylbenz-[a] anthracene and urethane feeding and by forced breeding.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Ascites; Breeding; Carcinoma; Cell Divisi | 1986 |
The changes of glycosaminoglycan in the growth of urethane-induced mouse mammary tumors.
Topics: Adenocarcinoma; Animals; Female; Glycosaminoglycans; Mammary Neoplasms, Experimental; Mice; Mice, In | 1989 |
The prenatal exposure of mice to urethan and the consequent development of tumors in various tissues.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Carcinoma, Hepatocellular; Female; Liver Neoplasms; L | 1967 |
Sensitivity of a lung cell in the developing mouse embryo to tumor induction by urethan.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Cell Differentiation; Dose-Response Relationship, Dru | 1974 |
Electron microscopic study of interstitial pneumonia, with special reference to alveolar epithelial cells.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Amphibians; Animals; Biopsy; Birds; Epithelium; Female; Humans | 1972 |
Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice.
Topics: Adenocarcinoma; Animals; Benz(a)Anthracenes; Carcinogens; Hyperplasia; Mammary Neoplasms, Experiment | 1974 |
Study of the potential carcinogenicity of topical drug. Suggestions for a new experimental approach.
Topics: Adenocarcinoma; Administration, Topical; Animals; Anti-Inflammatory Agents; Bronchial Neoplasms; Car | 1971 |
Dose-response studies in experimentally induced lung tumours.
Topics: Adenocarcinoma; Adenoma; Air Pollution; Animals; Benz(a)Anthracenes; Benzopyrenes; Carcinogens; Carc | 1971 |
Susceptibility of guinea pigs to chemical carcinogens: 7,12-Dimethylbenz(a)anthracene and urethan.
Topics: Adenocarcinoma; Age Factors; Animals; Animals, Newborn; Benz(a)Anthracenes; Female; Guinea Pigs; Inj | 1970 |
Tumor induction by repeated injections of urethan in newborn and adult hamsters: age influence. II.
Topics: Adenocarcinoma; Adenoma; Age Factors; Animals; Animals, Newborn; Cecal Neoplasms; Colonic Neoplasms; | 1971 |
Tumours of the intestines induced in rats by intraperitoneal injections of N-methyl- and N-ethyl-N-nitrosourethanes.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Female; Injections, Intraperitoneal; Intestinal Neopl | 1968 |
Inhibiton of protein synthesis in mammalian cells by actinobolin.
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Carbon Isotopes; Cell Line; Cell-Free System; Cultur | 1969 |